Blue Jet Healthcare has released its financial results for the quarter and financial year ended March 31, 2026. The company reported an annual revenue of ₹10,159.75 million and a net profit of ₹2,478.16 million. Alongside these results, the Board has recommended a final dividend of ₹1.20 per equity share and approved a strategic capital-raising proposal of up to ₹10,000 million to support future growth and operations.
Financial Performance Overview
For the financial year ended March 31, 2026, Blue Jet Healthcare achieved a robust financial performance with total income reaching ₹10,159.75 million. The company recorded a profit after tax of ₹2,478.16 million, showcasing operational resilience throughout the fiscal year. In the final quarter (Q4) ending March 31, 2026, the company generated revenue of ₹2,346.68 million with a quarterly profit of ₹643.44 million.
Dividend Recommendation
Reflecting its commitment to delivering value to its stakeholders, the Board of Directors has recommended a final dividend of ₹1.20 per equity share, representing a 60% payout on shares with a face value of ₹2. This recommendation is subject to approval by shareholders at the forthcoming Annual General Meeting, with record and payment dates to be announced at a later time.
Strategic Capital Raising
The company has announced a significant proposal to raise funds of up to ₹10,000 million. This capital will be generated through the issuance of various instruments, including equity shares, convertible debentures, or other equity-linked securities. These funds may be raised in one or more tranches through qualified institutions placements, preferential issues, or other permissible methods. This strategic move is designed to provide the necessary financial flexibility to support the company’s long-term business objectives.
Corporate Governance Updates
In addition to financial and expansion plans, the company has confirmed the re-appointment of M/s. H.H. Chimthanawala & Co. as the Internal Auditor for the 2026-27 financial year. Furthermore, the company will convene an Extra-Ordinary General Meeting on June 17, 2026, to deliberate on the aforementioned fund-raising initiatives. This meeting will be conducted via video conferencing to facilitate shareholder participation.
Source: BSE
